Literature DB >> 17674373

Plasma catecholamines and ischemic heart disease.

Jana Slavíková1, Jitka Kuncová, Ondrej Topolcan.   

Abstract

Plasma levels of norepinephrine and epinephrine were measured in 84 patients aged 56 +/- 9 (mean +/- SD) years with chronic ischemic heart disease (IHD), anterior acute myocardial infarction (AMI), posterior AMI, acute or chronic IHD associated with various types of electrical instability and in the control subjects. During the first day of hospitalization, plasma epinephrine levels were higher in patients with AMI in both localizations and chronic IHD in comparison with control values. There were no significant differences in plasma epinephrine levels among these groups of patients. However, in the same time period, plasma norepinephrine concentrations in patients with chronic IHD and posterior AMI did not differ from the control values; in patients with anterior AMI they reached by approximately 60% higher values than in the control group. Moreover, all myocardial lesions showing different types of electrical instability were associated with increased plasma levels of both norepinephrine and epinephrine. In conclusion, high plasma levels of epinephrine may result from sympathoadrenal activation. High plasma levels of norepinephrine in patients with anterior AMI and no change in patients with posterior AMI suggest a rather myocardial than an extramyocardial origin of plasma norepinephrine level in anterior AMI. Norepinephrine released from the ischemic area might contribute to the electrical instability of the myocardium and generation of dysrrhythmias.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17674373      PMCID: PMC6652865          DOI: 10.1002/clc.20099

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  25 in total

Review 1.  The role of beta-adrenergic blocking agents in preventing sudden cardiac death.

Authors:  B Pitt
Journal:  Circulation       Date:  1992-01       Impact factor: 29.690

Review 2.  Assessment of cardiovascular autonomic function.

Authors:  Roy Freeman
Journal:  Clin Neurophysiol       Date:  2006-02-07       Impact factor: 3.708

3.  Catecholaminergic neurons in the rat intrinsic cardiac nervous system.

Authors:  Jana Slavíková; Jitka Kuncová; Josef Reischig; Magda Dvoráková
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

Review 4.  Adrenergic mechanisms in myocardial infarction: cardiac and systemic catecholamine release.

Authors:  A Schömig
Journal:  J Cardiovasc Pharmacol       Date:  1988       Impact factor: 3.105

Review 5.  Myocardial infarction. Effects of beta-blockade.

Authors:  A Hjalmarson; G Olsson
Journal:  Circulation       Date:  1991-12       Impact factor: 29.690

6.  Systemic neurohumoral activation and vasoconstriction during pacing-induced acute myocardial ischemia in patients with stable angina pectoris.

Authors:  W J Remme; P W de Leeuw; M Bootsma; M P Look; D A Kruijssen
Journal:  Am J Cardiol       Date:  1991-07-15       Impact factor: 2.778

7.  Phenylethanolamine N-methyltransferase gene expression in transplanted human heart.

Authors:  E Goncalvesova; O Krizanova; L Micutkova; B Mravec; L Ksinantova; J Fabian; R Kvetnansky
Journal:  Transplant Proc       Date:  2005-03       Impact factor: 1.066

Review 8.  Prevention of ventricular fibrillation, acute myocardial infarction (myocardial necrosis), heart failure, and mortality by bretylium: is ischemic heart disease primarily adrenergic cardiovascular disease?

Authors:  Marvin Bacaner; James Brietenbucher; John LaBree
Journal:  Am J Ther       Date:  2004 Sep-Oct       Impact factor: 2.688

9.  Nonexocytotic release of endogenous noradrenaline in the ischemic and anoxic rat heart: mechanism and metabolic requirements.

Authors:  A Schömig; S Fischer; T Kurz; G Richardt; E Schömig
Journal:  Circ Res       Date:  1987-02       Impact factor: 17.367

10.  In vivo measurement of neuronal uptake of norepinephrine in the human heart.

Authors:  D S Goldstein; J E Brush; G Eisenhofer; R Stull; M Esler
Journal:  Circulation       Date:  1988-07       Impact factor: 29.690

View more
  8 in total

Review 1.  Neuroendocrine System Regulatory Mechanisms: Acute Coronary Syndrome and Stress Hyperglycaemia.

Authors:  Ricardo A Perez de la Hoz; Sandra Patricia Swieszkowski; Federico Matias Cintora; Jose Martin Aladio; Claudia Mariana Papini; Maia Matsudo; Alejandra Silvia Scazziota
Journal:  Eur Cardiol       Date:  2018-08

2.  Coronary vessel diameters during and after primary percutaneous coronary artery intervention.

Authors:  M Sahin; S Demir; G Kocabay; M Bulut; G Alici; B Ozkan; A Fedakar; M Turkmen; B Boztosun
Journal:  Herz       Date:  2013-07-07       Impact factor: 1.443

3.  Common pathways and communication between the brain and heart: connecting post-traumatic stress disorder and heart failure.

Authors:  Marlene A Wilson; Israel Liberzon; Merry L Lindsey; Yana Lokshina; Victoria B Risbrough; Renu Sah; Susan K Wood; John B Williamson; Francis G Spinale
Journal:  Stress       Date:  2019-06-04       Impact factor: 3.493

4.  Essential Role of Ovarian Hormones in Susceptibility to the Consequences of Witnessing Social Defeat in Female Rats.

Authors:  Julie E Finnell; Brandon L Muniz; Akhila R Padi; Calliandra M Lombard; Casey M Moffitt; Christopher S Wood; L Britt Wilson; Lawrence P Reagan; Marlene A Wilson; Susan K Wood
Journal:  Biol Psychiatry       Date:  2018-01-31       Impact factor: 13.382

5.  Beta1-adrenoceptor polymorphism predicts flecainide action in patients with atrial fibrillation.

Authors:  Amir M Nia; Evren Caglayan; Natig Gassanov; Tom Zimmermann; Orhan Aslan; Martin Hellmich; Firat Duru; Erland Erdmann; Stephan Rosenkranz; Fikret Er
Journal:  PLoS One       Date:  2010-07-02       Impact factor: 3.240

6.  Incidence and long-term outcomes of adult patients with diabetic ketoacidosis admitted to intensive care: A retrospective cohort study.

Authors:  Aksha Ramaesh
Journal:  J Intensive Care Soc       Date:  2016-04-25

7.  Facilitation of ischaemia-induced ventricular fibrillation by catecholamines is mediated by β1 and β2 agonism in the rat heart in vitro.

Authors:  Catherine D E Wilder; Nikoleta Pavlaki; Tutku Dursun; Paul Gyimah; Ellice Caldwell-Dunn; Antonella Ranieri; Hannah R Lewis; Michael J Curtis
Journal:  Br J Pharmacol       Date:  2018-04-02       Impact factor: 8.739

8.  Circulating primers enhance platelet function and induce resistance to antiplatelet therapy.

Authors:  T A Blair; S F Moore; I Hers
Journal:  J Thromb Haemost       Date:  2015-06-25       Impact factor: 5.824

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.